Report Thumbnail
Product Code MM0911423467VI
Published Date 2023/11/6
English212 PagesGlobal

Surface Disinfectant Market by Composition (Alcohols, Chlorine, Quaternary Ammonium), Type (Liquid, Wipes, Sprays), Application (Surface, Instrument), End-User (Hospital, Diagnostic and Research Laboratories), & Region - Global Forecast to 2028MedicalDevice_MedTech Market


Report Thumbnail
Product Code MM0911423467VI◆The Nov 2025 edition is also likely available. We will check with the publisher immediately.
Published Date 2023/11/6
English 212 PagesGlobal

Surface Disinfectant Market by Composition (Alcohols, Chlorine, Quaternary Ammonium), Type (Liquid, Wipes, Sprays), Application (Surface, Instrument), End-User (Hospital, Diagnostic and Research Laboratories), & Region - Global Forecast to 2028MedicalDevice_MedTech Market



Abstract


Summary

The surface disinfectants market is projected to reach USD 4.2 billion by 2028 from USD 2.6 biillion in 2023, at a CAGR of 9.4%. Growing awareness of sanitization and cleanliness due to the prevalence of COVID-19 and the increasing demand for infection control strategies to reduce the incidence of hospital-acquired diseases are two factors driving the growth of the market. The development of alternative technologies and the growing number of negative effects of chemical disinfectants, on the other hand, are the main obstacles impeding the expansion of this industry. “The alcohol segment held the biggest share in the surface disinfectant market, by composition, along the forecast period” The surface disinfectant market is segregated into alcohols, chlorine compounds, quaternary ammonium compounds, hydrogen peroxide, peracetic acid, and other compositions based on composition. In 2022, the alcohol segment was holding the top share in the surface disinfectant market. The rapid evaporation and effective killing of germs by alcohol-based disinfectants, coupled with the surge in demand for hospital-grade and household disinfectants as a result of viral illnesses, are anticipated to propel the expansion of this market segment. “The liquid segment accounted for the highest growth rate in the surface disinfectant market, by type, during the forecast period” There are three categories in the surface disinfection market: liquid, wipes, and sprays.In the surface disinfectant market in 2022, the liquid category had the fastest growth rate. The broad usage of liquid disinfectants for hospital-acquired infection prevention and their accompanying low cost when compared to sprays and wipes are the primary factors driving their substantial market dominance. “Instrument Disinfection segment accounted for the highest CAGR.” Based on application, surface disinfectant market has been segmented into surface disinfection, instrument disinfection and other applications. The instrument disinfection market has the greatest compound annual growth rate (CAGR) in 2022. This can be linked to the proliferation of COVID-19 and the increasing number of strict laws governing the use of surface disinfectants, which have raised awareness of cleanliness and sanitization. “Hospital settings segment accounted for the highest share” Based on end-user, the surface disinfectant market has been segmented into hospital settings, diagnostic laboratories, pharmaceutical & biotechnology companies, and research laboratories. In 2022, the largest share belonged to the hospital settings segment. This is explained by the growing need for infection control measures to reduce the incidence of hospital-acquired infections as well as the growing use of more recent surface disinfectants for sanitization. "Asia Pacific: The fastest-growing region surface disinfectant market." The global surface disinfectant market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Over the course of the forecast period, the Asia Pacific region is expected to record the highest CAGR. The increasing geriatric population in several APAC countries (combined with the rising prevalence of chronic disorders), the expansion of private hospitals into rural areas, the presence of high-growth markets in the region, and rising per capita income are all factors driving up healthcare spending. It is also expected that this region's favourable labour laws and affordable labour will spur market expansion. Breakdown of supply-side primary interviews, by company type, designation, and region: • By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%) • By Designation: C-level (27%), Director-level (18%), and Others (55%) • By Region: North America (51%), Europe (21%), Asia- Pacific (18%), Latin America (6%), and Middle East & Africa(4%) Prominent companies include 3M (US), Procter & Gamble (US), Reckitt Benckiser Group Plc (UK), Ecolab (US), STERIS (US), The Clorox Company (US), SC Johnson Professional (US), CarrollCLEAN (US), PAUL HARTMANN AG (Germany), Sanosil AG (Switzerland), Metrex Research, LLC (US), Whiteley Corporration (Australia), GOJO Industries, Inc. (US), Acuro Organics Limited (India), Pharmax Pharmaceuticals FZ-LLC (Canada), PDI, Inc. (US), Becto, Inc. (US), GESCO Healthcare Pvt. Ltd. (India), MEDALKAN (Greece), Ruhof (US), Cetylite, Inc. (US), Micro-Scientific, LLC (US), Pal International (UK), Brulin Holding Company, Inc. (US), and CareNow Medical Private Limited (India). Research Coverage This research report categorizes the Surface disinfectant market by products & service, technology, end user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the Surface disinfectant market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements, new product & service launches, mergers and acquisitions, and recent developments associated with the Surface disinfectant market. Competitive analysis of upcoming startups in the Surface disinfectant market ecosystem is covered in this report. Reasons to buy this report The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall surface disinfectant market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. The report provides insights on the following pointers: • Analysis of key drivers (High prevalence of HAIs, advancements in surface disinfectants for sanitization), restraints (Adverse effects of chemical disinfectants, Alternative Technologies), opportunities (Rising healthcare expenditure, Increasing Demand from Emerging Economies), and challenges (stringent regulations) influencing the growth of the surface disinfectant market. • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the surface disinfectant market • Market Development: Comprehensive information about lucrative markets – the report analyses the surface disinfectant market across varied regions. • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the surface disinfectant market • Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like 3M (US), Procter & Gamble (US), Reckitt Benckiser Group Plc (UK), Ecolab (US), STERIS (US), The Clorox Company (US), among others in surface disinfectant market

Table of Contents

  • 1 INTRODUCTION 29

    • 1.1 STUDY OBJECTIVES 29
    • 1.2 MARKET DEFINITION 29
      • 1.2.1 INCLUSIONS & EXCLUSIONS 30
    • 1.3 STUDY SCOPE 30
      • 1.3.1 SURFACE DISINFECTANTS MARKET 30
      • 1.3.2 REGIONAL SCOPE 31
      • 1.3.3 YEARS CONSIDERED 31
    • 1.4 CURRENCY 32
    • 1.5 LIMITATIONS 32
    • 1.6 STAKEHOLDERS 32
    • 1.7 SUMMARY OF CHANGES 33
  • 2 RESEARCH METHODOLOGY 34

    • 2.1 RESEARCH DATA 34
    • 2.2 RESEARCH APPROACH 34
      • 2.2.1 SECONDARY DATA 35
        • 2.2.1.1 Key data from secondary sources 35
      • 2.2.2 PRIMARY DATA 36
        • 2.2.2.1 Primary sources 37
        • 2.2.2.2 Key data from primary sources 37
        • 2.2.2.3 Key industry insights 38
        • 2.2.2.4 Breakdown of primary interviews 38
    • 2.3 MARKET SIZE ESTIMATION 39
      • 2.3.1 BOTTOM-UP APPROACH 39
        • 2.3.1.1 Approach 1: Company revenue estimation approach 40
        • 2.3.1.2 Approach 2: Presentations of companies and primary interviews 40
        • 2.3.1.3 Growth forecast 40
        • 2.3.1.4 CAGR projections 41
      • 2.3.2 TOP-DOWN APPROACH 41
    • 2.4 MARKET BREAKDOWN & DATA TRIANGULATION 42
    • 2.5 MARKET SHARE ANALYSIS 44
    • 2.6 STUDY ASSUMPTIONS 44
    • 2.7 RISK ASSESSMENT 45
      • 2.7.1 RISK ASSESSMENT: SURFACE DISINFECTANTS MARKET 45
    • 2.8 RECESSION IMPACT 45
  • 3 EXECUTIVE SUMMARY 47

  • 4 PREMIUM INSIGHTS 51

    • 4.1 SURFACE DISINFECTANTS MARKET OVERVIEW 51
    • 4.2 SURFACE DISINFECTANTS MARKET SHARE, BY COMPOSITION, 2023 VS. 2028 51
    • 4.3 SURFACE DISINFECTANTS MARKET SHARE, BY TYPE, 2023 VS. 2028 52
    • 4.4 SURFACE DISINFECTANTS MARKET SHARE, BY APPLICATION, 2023 VS. 2028 52
    • 4.5 SURFACE DISINFECTANTS MARKET SHARE, BY END USER, 2023 VS. 2028 53
    • 4.6 SURFACE DISINFECTANTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 53
  • 5 MARKET OVERVIEW 54

    • 5.1 INTRODUCTION 54
    • 5.2 MARKET DYNAMICS 54
      • 5.2.1 DRIVERS 55
        • 5.2.1.1 Rising demand for infection control measures to curb hospital-acquired infections 55
        • 5.2.1.2 Increasing use of newer surface disinfectants for sanitization 56
        • 5.2.1.3 Growing awareness of sanitization and hygiene after COVID-19 56
      • 5.2.2 RESTRAINTS 56
        • 5.2.2.1 Adverse effects of chemical disinfectants 56
        • 5.2.2.2 Increasing development of alternative technologies 57
      • 5.2.3 OPPORTUNITIES 58
        • 5.2.3.1 Increasing healthcare expenditure and focus on emerging economies 58
      • 5.2.4 CHALLENGES 58
        • 5.2.4.1 Stringent regulations 58
    • 5.3 PRICING ANALYSIS 59
      • 5.3.1 PRICING MODEL ANALYSIS 59
      • 5.3.2 AVERAGE SELLING PRICE TREND 59
    • 5.4 PATENT ANALYSIS 61
      • 5.4.1 PATENT ANALYSIS OF SURFACE DISINFECTANT PRODUCTS 61
    • 5.5 TRADE ANALYSIS 62
      • 5.5.1 TRADE ANALYSIS FOR DISINFECTANTS 62
    • 5.6 VALUE CHAIN ANALYSIS 63
    • 5.7 SUPPLY CHAIN ANALYSIS 64
    • 5.8 ECOSYSTEM ANALYSIS 65
      • 5.8.1 ROLE IN ECOSYSTEM 65
    • 5.9 PORTER’S FIVE FORCES ANALYSIS 66
      • 5.9.1 THREAT OF NEW ENTRANTS 66
      • 5.9.2 THREAT OF SUBSTITUTES 66
      • 5.9.3 BARGAINING POWER OF BUYERS 66
      • 5.9.4 BARGAINING POWER OF SUPPLIERS 66
      • 5.9.5 DEGREE OF COMPETITION 67
    • 5.10 PESTLE ANALYSIS 67
    • 5.11 REGULATORY ANALYSIS 68
      • 5.11.1 REGULATORY JURISDICTION 68
      • 5.11.2 REGULATORY ANALYSIS, BY REGION 69
      • 5.11.3 NORTH AMERICA 69
        • 5.11.3.1 US 69
        • 5.11.3.2 Canada 69
      • 5.11.4 EUROPE 69
      • 5.11.5 ASIA PACIFIC 70
        • 5.11.5.1 Japan 70
        • 5.11.5.2 India 70
        • 5.11.5.3 China 70
      • 5.11.6 LATIN AMERICA 70
        • 5.11.6.1 Brazil 71
        • 5.11.6.2 Mexico 71
      • 5.11.7 MIDDLE EAST 71
      • 5.11.8 AFRICA 71
    • 5.12 TECHNOLOGY ANALYSIS 71
    • 5.13 KEY CONFERENCES & EVENTS 72
    • 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 73
    • 5.15 KEY STAKEHOLDERS & BUYING CRITERIA 73
      • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 73
      • 5.15.2 BUYING CRITERIA 74
    • 5.16 CASE STUDY ANALYSIS 75
      • 5.16.1 CASE STUDY: SURFACE DISINFECTION COMPATIBILITY AFFECTS SURFACES OF MEDICAL DEVICES 75
  • 6 SURFACE DISINFECTANTS MARKET, BY COMPOSITION 76

    • 6.1 INTRODUCTION 77
    • 6.2 ALCOHOL 77
      • 6.2.1 ABILITY OF ALCOHOL-BASED DISINFECTANTS TO EFFICIENTLY KILL GERMS TO DRIVE MARKET GROWTH 77
    • 6.3 CHLORINE COMPOUNDS 79
      • 6.3.1 BLEACHING AND GERMICIDAL PROPERTIES OF CHLORINE TO DRIVE DEMAND 79
    • 6.4 QUATERNARY AMMONIUM COMPOUNDS 80
      • 6.4.1 GROWING USE OF QUATERNARY AMMONIUM COMPOUNDS AS FLOOR DISINFECTANTS TO SUPPORT MARKET GROWTH 80
    • 6.5 HYDROGEN PEROXIDE 81
      • 6.5.1 LOW TOXICITY OF HYDROGEN PEROXIDE TO DRIVE ADOPTION 81
    • 6.6 PERACETIC ACID 82
      • 6.6.1 FAVORABLE FEATURES OF PERACETIC ACID OVER OTHER SUBSTITUTES TO PROPEL MARKET GROWTH 82
    • 6.7 OTHER COMPOSITIONS 83
  • 7 SURFACE DISINFECTANTS MARKET, BY TYPE 85

    • 7.1 INTRODUCTION 86
    • 7.2 LIQUIDS 86
      • 7.2.1 INEXPENSIVE AND EFFECTIVE NATURE OF LIQUID FORMULATIONS TO DRIVE MARKET GROWTH 86
    • 7.3 WIPES 87
      • 7.3.1 ALCOHOL-BASED WIPES 89
        • 7.3.1.1 Bactericidal, tuberculocidal, and fungicidal properties of alcohol wipes to drive demand 89
      • 7.3.2 QUATERNARY AMMONIUM COMPOUND-BASED WIPES 90
        • 7.3.2.1 Superior germicidal activity with high protein load to increase market demand 90
      • 7.3.3 OTHER WIPES 90
    • 7.4 SPRAYS 92
      • 7.4.1 GROWING USE OF SPRAYS IN FOGGING TECHNIQUES FOR ANTIMICROBIAL CONTROL IN HOSPITAL ROOMS TO BOOST MARKET 92
  • 8 SURFACE DISINFECTANTS MARKET, BY APPLICATION 93

    • 8.1 INTRODUCTION 94
    • 8.2 SURFACE DISINFECTION 94
      • 8.2.1 GROWING PREVALENCE OF HAIS TO BOOST DEMAND FOR SURFACE DISINFECTANTS 94
    • 8.3 INSTRUMENT DISINFECTION 96
      • 8.3.1 GROWING USE OF VARIOUS INSTRUMENTS AND MEDICAL DEVICES IN HOSPITALS AND LABORATORIES TO DRIVE GROWTH 96
    • 8.4 OTHER APPLICATIONS 97
  • 9 SURFACE DISINFECTANTS MARKET, BY END USER 98

    • 9.1 INTRODUCTION 99
    • 9.2 HOSPITAL SETTINGS 99
      • 9.2.1 HIGH PREVALENCE OF HAIS TO FUEL USE OF SURFACE DISINFECTANTS IN HOSPITALS 99
    • 9.3 DIAGNOSTIC LABORATORIES 101
      • 9.3.1 HIGH DEMAND FOR CLEANROOMS FOR SAMPLE ANALYSIS TO SUPPORT GROWTH 101
    • 9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 102
      • 9.4.1 RISING PHARMACEUTICAL & BIOTECHNOLOGY INVESTMENTS TO FAVOR MARKET GROWTH 102
    • 9.5 RESEARCH LABORATORIES 103
      • 9.5.1 NEED FOR GOOD AND STERILIZED RESEARCH ENVIRONMENTS TO DRIVE DEMAND FOR SURFACE DISINFECTANTS 103
  • 10 SURFACE DISINFECTANTS MARKET, BY REGION 104

    • 10.1 INTRODUCTION 105
    • 10.2 NORTH AMERICA 106
      • 10.2.1 NORTH AMERICA: RECESSION IMPACT 106
      • 10.2.2 US 109
        • 10.2.2.1 US to dominate North American surface disinfectants market during forecast period 109
      • 10.2.3 CANADA 112
        • 10.2.3.1 High prevalence of HAIs and increasing patient population to drive market growth in Canada 112
    • 10.3 EUROPE 114
      • 10.3.1 EUROPE: RECESSION IMPACT 115
      • 10.3.2 GERMANY 117
        • 10.3.2.1 High prevalence of HAIs in hospitals and ICUs to support market growth 117
      • 10.3.3 FRANCE 120
        • 10.3.3.1 Favorable government initiatives to support market growth in France 120
      • 10.3.4 UK 123
        • 10.3.4.1 Growing patient population and government initiatives to drive demand for surface disinfectants in UK 123
      • 10.3.5 ITALY 125
        • 10.3.5.1 Large geriatric population in Italy to support market growth 125
      • 10.3.6 SPAIN 127
        • 10.3.6.1 Increasing prevalence of chronic diseases to drive use of surface disinfectants 127
      • 10.3.7 REST OF EUROPE 130
    • 10.4 ASIA PACIFIC 132
      • 10.4.1 ASIA PACIFIC: RECESSION IMPACT 132
      • 10.4.2 CHINA 136
        • 10.4.2.1 High and aging population to drive market growth in China 136
      • 10.4.3 JAPAN 139
        • 10.4.3.1 Well-developed healthcare system and universal healthcare reimbursement policy to drive market growth 139
      • 10.4.4 INDIA 141
        • 10.4.4.1 Large patient population to boost growth 141
      • 10.4.5 AUSTRALIA 144
        • 10.4.5.1 Increasing awareness and government initiatives for infection control to drive market growth 144
      • 10.4.6 REST OF ASIA PACIFIC 146
    • 10.5 LATIN AMERICA 149
      • 10.5.1 LATIN AMERICA: RECESSION IMPACT 149
      • 10.5.2 BRAZIL 152
        • 10.5.2.1 Increased investment in healthcare to support market growth 152
      • 10.5.3 MEXICO 154
        • 10.5.3.1 Rising prevalence of chronic disorders to aid market growth 154
      • 10.5.4 REST OF LATIN AMERICA 156
    • 10.6 MIDDLE EAST & AFRICA 159
      • 10.6.1 INCREASING AWARENESS AND FOCUS ON IMPROVING HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET GROWTH 159
      • 10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 160
  • 11 COMPETITIVE LANDSCAPE 162

    • 11.1 OVERVIEW 162
    • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 162
      • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SURFACE DISINFECTANTS MARKET 162
    • 11.3 REVENUE ANALYSIS 164
    • 11.4 MARKET SHARE ANALYSIS 164
    • 11.5 COMPANY EVALUATION MATRIX 166
      • 11.5.1 STARS 166
      • 11.5.2 EMERGING LEADERS 166
      • 11.5.3 PERVASIVE PLAYERS 166
      • 11.5.4 PARTICIPANTS 166
      • 11.5.5 COMPANY FOOTPRINT ANALYSIS 167
    • 11.6 START-UP/SME EVALUATION MATRIX 169
      • 11.6.1 PROGRESSIVE COMPANIES 169
      • 11.6.2 RESPONSIVE COMPANIES 169
      • 11.6.3 DYNAMIC COMPANIES 169
      • 11.6.4 STARTING BLOCKS 169
    • 11.7 COMPETITIVE SCENARIO & TRENDS 171
      • 11.7.1 PRODUCT LAUNCHES & APPROVALS 171
      • 11.7.2 DEALS 172
  • 12 COMPANY PROFILES 173

    • 12.1 KEY PLAYERS 173
      • 12.1.1 3M 173
      • 12.1.2 PROCTER & GAMBLE 177
      • 12.1.3 RECKITT BENCKISER GROUP PLC 180
      • 12.1.4 ECOLAB 184
      • 12.1.5 STERIS 189
      • 12.1.6 THE CLOROX COMPANY 193
      • 12.1.7 PAUL HARTMANN AG (BODE CHEMIE GMBH) 196
      • 12.1.8 SC JOHNSON PROFESSIONAL 199
      • 12.1.9 CARROLLCLEAN 200
    • 12.2 OTHER PLAYERS 202
      • 12.2.1 SANOSIL LTD 202
      • 12.2.2 METREX RESEARCH, LLC 203
      • 12.2.3 WHITELEY CORPORATION 204
      • 12.2.4 ACURO ORGANICS LIMITED 205
      • 12.2.5 GOJO INDUSTRIES, INC 205
      • 12.2.6 PHARMAX LIMITED 206
      • 12.2.7 PDI, INC 206
      • 12.2.8 BECTO INC 207
      • 12.2.9 GESCO HEALTHCARE PVT. LTD 207
      • 12.2.10 MEDALKAN 208
      • 12.2.11 RUHOF 208
      • 12.2.12 CARENOW MEDICAL PVT. LTD 209
      • 12.2.13 CETYLITE, INC 209
      • 12.2.14 MICRO-SCIENTIFIC, LLC 210
      • 12.2.15 PAL INTERNATIONAL 210
      • 12.2.16 BRULIN HOLDING COMPANY, INC 211
  • 13 APPENDIX 212

    • 13.1 DISCUSSION GUIDE 212
    • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 216
    • 13.3 CUSTOMIZATION OPTIONS 218
    • 13.4 RELATED REPORTS 218
    • 13.5 AUTHOR DETAILS 219
USD 4,950 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.